Illumina Has Lost its Positive Momentum

Illumina (ILMN), the maker of gene sequencing systems, had a banner 2018 after it introduced its Novaseq system. Now in 2019, comparisons will be tougher.

Customers Are Upgrading With Illumina

Illumina (ILMN) makes gene-sequencing machines used to analyze DNA. ILMN’s new NovaSeq machines are so good customers are upgrading.

Better Profits Expected for Illumina in 2018

Illumina (ILMN) is expected to have accelerating profit growth in 2018 as its new gene sequencing system is generating momentum. But is the good news priced into ILMN stock?

Illumina Is In Need of Some Upgrades

Illumina (ILMN) is in need of upgrades. Not analyst upgrades, customer upgrades. ILMN’s NovaSeq is superior to its HiSeqX machines, but costs to upgrade are high.